From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
Group
Cases of diabetes
Incidence of diabetes mellitus (%)
Cases of normal blood glucose
Reversion rate (%)
The treatment group
37
20.3Â %
82
45.1Â %
The control group
59
32.8Â %
54
30Â %